Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain

Current Medical Research and Opinion

Volumn 28, Issue 5, 2012, Pages 833-845

  Wolff, Robert F ^a   Aune, Dagfinn ^b   Truyers, Carla ^c   Hernandez, Adrian V ^a,d   Misso, Kate ^a   Riemsma, Rob ^a   Kleijnen, Jos ^a,e  

^a KLEIJNEN SYSTEMATIC REVIEWS LTD   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d LERNER RESEARCH INSTITUTE   (United States)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Administration; Buprenorphine; Chronic pain; Cutaneous; Drug toxicity; Fentanyl; Pain; Transdermal patch

Indexed keywords

BUPRENORPHINE; FENTANYL; METHADONE; MORPHINE; PLACEBO;

ANALGESIA; ARTICLE; CANCER PAIN; CHRONIC PAIN; COMPARATIVE STUDY; CONSTIPATION; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; META ANALYSIS; NAUSEA; OUTCOME ASSESSMENT; PAIN ASSESSMENT; QUANTITATIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; SLEEP DEPRIVATION; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; VOMITING;

ADMINISTRATION, ORAL; ANALGESICS, OPIOID; BUPRENORPHINE; CHRONIC PAIN; CONSTIPATION; FENTANYL; HUMANS; MORPHINE; NAUSEA; PAIN; PAIN MEASUREMENT; TRANSDERMAL PATCH; TREATMENT OUTCOME;

EID: 84861175026     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.678938     Document Type: Article

References (30)

1. Reid KJ, Harker J, Bala MM, et al. Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact. Curr Med Res Opin 2011;27:449-62
2. World Health Organization. WHO's pain ladder [Internet]. 2011 [Last accessed 23 March 2011]. Available from: http://www.who.int/cancer/palliative/ painladder/en/
3. Davis M, Glare P, Hardy J (eds). Opioids in Cancer Pain. Oxford: Oxford University Press, 2005
4. Sorge J, Sittl R. Transdermal buprenorphine in the treatment of chronic pain: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 2004;26:1808-20 (Pubitemid 40089494)
5. Sittl R, Griessinger N, Likar R. Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, doubleblind, placebo-controlled trial. Clin Ther 2003;25:150-68 (Pubitemid 36206743)
6. Pergolizzi J, Aloisi AM, Dahan A, et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract 2010;10:428-50
7. Medsafe. DBL Fentanyl Injection: datasheet [Internet]. Wellington, NZ: New Zealand Medicines and Medical Devices Safety Authority, 2008 [Last accessed 23 March 2011]. Available from: http://www.medsafe.govt.nz/profs/Datasheet/f/ FentanylcitrateinjUSP.htm
8. CHANGE PAIN Advisory Panel. CHANGE PAIN: opioid treatment. Aachen: Grunenthal Group, 2010
9. Centre for Reviews and Dissemination. Systematic Reviews: CRD's guidance for undertaking reviews in health care [Internet]. York: University of York, 2009 [Last accessed 23 March 2011] Available from: http://www.york.ac .uk/inst/crd/SysRev/!SSL!/WebHelp/SysRev3.htm
10. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions [Internet]. Version 5.1.0 [updated March 2011]: The Cochrane Collaboration, 2011 [Last accessed 23 March 2011]. Available from: http://www.cochrane-handbook.org/
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88 (Pubitemid 17189972)
12. Puhan MA, Bachmann LM, Kliejnen J, et al. Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC Med 2009;14:2
13. Pace MC, Passavanti MB, Grella E, et al. Buprenorphine in long-term control of chronic pain in cancer patients. Front Biosci 2007;12:1291-9 (Pubitemid 46846834)
14. Böhme K, Likar R. Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled study Pain Clin 2003;15:193-202 (Pubitemid 36644341)
15. Poulain P, Denier W, Douma J, et al. Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain. J Pain Symptom Manag 2008;36:117-25 (Pubitemid 352010492)
16. Ahmedzai S. TTS-Fentanyl vs oral morphine in cancer pain [abstract no: 874]. Eur J Cancer 1995;31(Suppl 6):S182
17. Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life. J Pain Symptom Manag 1997;13:254-61 (Pubitemid 27240678)
18. Allan L, Hays H, Jensen NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001;322:1154-8 (Pubitemid 32434223)
19. Allan L, Kalso E. Randomized trial of transdermal fentanyl and sustained release oral morphine in chronic low back pain. Paper presented at Pain in Europe IV. Fourth Congress of the European Federation of IASP Chapters (EFIC), 2-6 September 2003, Prague
20. Allan L, Richarz U, Simpson K, et al. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain. Spine 2005;30:2484-90 (Pubitemid 41669082)
21. Mercadante S, Porzio G, Ferrera P, et al. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain 2008;12:1040-6
22. Öztürk T, Karadibak K, Catal D, et al. [Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer]. Agri Derg 2008;20:20-5
23. van Seventer R, Smit JM, Schipper RM, et al. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain. Curr Med Res Opin 2003;19:457-69 (Pubitemid 37122037)
24. Wolff RF, Reid K, di Nissio M, et al. Systematic review of adverse events of Buprenorphine patch versus Fentanyl patch in patients with chronic moderate to severe pain. Pain Manag. Forthcoming 2012.
25. Wong JO, Chiu GL, Tsao CJ, et al. Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain. Acta Anaesthesiol Sin 1997;35:25-32 (Pubitemid 127735941)
26. Kongsgaard U, Poulain P. Transdermal fentanyl for pain control in adults with chronic cancer pain. Eur J Pain 1998;2:53-62 (Pubitemid 28248320)
27. Kongsgaard UE, Poulain P. Transdermal fentanyl for pain control in chronic cancer pain. Support Care Cancer 1997;5(Suppl 1):177
28. Langford R, McKenna F, Ratcliffe S, et al. Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: a randomized, placebo-controlled trial. Arthritis Rheum 2006;54:1829-37 (Pubitemid 43877932)
29. Song F, Loke YK, Walsh T, et al. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ 2009;338:B1147
30. Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med 2010;7(3):e1000251